The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.,, ...
Ophthalmology Times

FDA approves Johnson & Johnson's TECNIS PureSee EDOF IOL

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Hosted on MSN

Intraocular lens (IOL) implants and cataracts: What you need to know

Medical Disclaimer: This article is provided for general information and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek advice from a qualified ...
Healio

Deferred IOL implantation leads to better outcomes in traumatic pediatric cataract

Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
MassDevice

Johnson & Johnson wins FDA nod for new intraocular lens

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
GlobalData on MSN

FDA approves J&J’s TECNIS PureSee intraocular lens

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
Healio

FDA approves Johnson & Johnson’s Tecnis PureSee IOL

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...